tiprankstipranks
Trending News
More News >
Cormedix (CRMD)
NASDAQ:CRMD
US Market
Advertisement

Cormedix (CRMD) Technical Analysis

Compare
1,350 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Cormedix’s (CRMD) Moving Averages Convergence Divergence (MACD) indicator is -0.54, suggesting Cormedix is a Buy.
Cormedix’s (CRMD) 20-Day exponential moving average is 12.08, while Cormedix’s (CRMD) share price is $11.07, making it a Sell.
Cormedix’s (CRMD) 50-Day exponential moving average is 12.06, while Cormedix’s (CRMD) share price is $11.07, making it a Sell.

Cormedix (CRMD) Pivot Points

Jul 18, 2025, 07:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.30
10.65
10.89
11.24
11.48
11.83
12.07
Fibonacci
10.65
10.88
11.01
11.24
11.47
11.60
11.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cormedix (CRMD) Moving Averages

Jul 18, 2025, 07:37 PM
Period
Simple
Exponential
MA5
11.23Sell
11.24Sell
MA10
11.35Sell
11.54Sell
MA20
12.56Sell
12.08Sell
MA50
12.70Sell
12.06Sell
MA100
10.74Buy
11.29Sell
MA200
10.49Buy
10.27Buy
Cormedix’s (CRMD) 10-Day exponential moving average is 11.54, while Cormedix’s (CRMD) share price is $11.07, making it a Sell.
Cormedix’s (CRMD) 100-Day exponential moving average is 11.29, while Cormedix’s (CRMD) share price is $11.07, making it a Sell.
Cormedix’s (CRMD) stock price is $11.07 and Cormedix’s (CRMD) 50-day simple moving average is 12.70, creating a Sell signal.
Cormedix’s (CRMD) stock price is $11.07 and Cormedix’s (CRMD) 100-day simple moving average is 10.74, creating a Buy signal.
Cormedix’s (CRMD) stock price is $11.07 and Cormedix’s (CRMD) 200-day simple moving average is 10.49, creating a Buy signal.

Cormedix (CRMD) Technical Indicators

Jul 18, 2025, 07:37 PM
Name
Value
Implied Action
RSI (14)
37.92
Neutral
STOCH (9,6)
18.71
Buy
STOCHRSI (14)
4.00
Buy
MACD (12,26)
-0.54
Buy
ADX (14)
20.07
Neutral
Williams %R
-96.46
Buy
CCI (14)
-68.78
Neutral
ATR (14)
0.65
-
Ultimate Oscillator
37.30
Neutral
ROC
-26.00
Sell
Cormedix’s (CRMD) Relative Strength Index (RSI) is 37.92, creating a Neutral signal.
Cormedix’s (CRMD) Trend Strength Indicator (ADX) is 20.07, creating a Neutral signal.
Cormedix’s (CRMD) Commodity Channel Index (CCI) is -68.78, creating a Neutral signal.
Cormedix’s (CRMD) Price Rate of Change (ROC) is -26.00, creating a Sell signal.

FAQ

Is CRMD a Buy, Hold, or Sell?
Based on CRMD’s technical indicators, CRMD is a Sell.
    What is CRMD’s RSI (14)?
    CRMD’s RSI (14) is 37.92, which suggests CRMD is a Neutral.
      What is CRMD’s MACD?
      CRMD’s MACD is -0.54, which suggests CRMD is a Buy.
        What is CRMD’s 5-day moving average?
        CRMD’s 5-day moving average is 11.23, which suggests CRMD is a Sell.
          What is CRMD’s 20-day moving average?
          CRMD 20-day moving average is 12.56, which suggests CRMD is a Sell.
            What is CRMD’s 50-day moving average?
            CRMD’s 50-day moving average is 12.70, which suggests CRMD is a Sell.
              What is CRMD’s 200-day moving average?
              CRMD’s 200-day moving average is 10.49, which suggests CRMD is a Buy.
                What is CRMD’s Williams % R (14)?
                CRMD’s Williams % R (14) is -96.46, which suggests CRMD is a Buy.
                  What is CRMD’s CCI (14)?
                  CRMD’s CCI (14) is -68.78, which suggests CRMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis